Follistatin and activin A production by the male reproductive tract.

Follistatin is a binding protein for the activin and inhibin family of hormones, regulating their biological activity. In the male reproductive tract, the interaction of these factors is likely to be involved in the regulation of the proliferation of several cell types. We have investigated the presence of follistatin and activin A in seminal plasma using specific immunoassays and have localized follistatin and activin/inhibin subunits in the adult human testis, prostate and seminal vesicle to establish their likely sources. High concentrations of immunoreactive follistatin were present in seminal plasma in normal men (mean 97.9 ng/ml; 1.43 ng/ml in peripheral plasma) and were similar in men with oligo/azoospermia and following vasectomy. Follistatin immunoreactivity was localized to both Leydig and Sertoli cells of the testis, and to epithelial cells of the prostate gland and seminal vesicle, which are likely to be the predominant sources of the hormone in seminal plasma. Activin A was also present in seminal plasma in normal men but was undetectable following vasectomy, thus deriving from the testis. Consistent with this finding, the betaA-subunit was immunolocalized in Sertoli and Leydig cells but was not present in seminal vesicle or prostate gland. The functional significance of the high concentrations of follistatin secreted into seminal plasma by the prostate gland and/or seminal vesicle is uncertain, but they may regulate the biological activity of testis-derived activin A and inhibin B.

[1]  R. Anderson,et al.  Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. , 1998, Human reproduction.

[2]  C. Welt,et al.  Activin Regulates βA-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells. , 1998, Endocrinology.

[3]  N. Groome,et al.  Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. , 1998, The Journal of endocrinology.

[4]  M. O’Bryan,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression and Localization of Activin Subunits and Follistatins in Tissues from Men with High Grade Prostate Cancer , 2022 .

[5]  G. Risbridger,et al.  Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. , 1997, The Journal of endocrinology.

[6]  J. Mather,et al.  Activins, Inhibins, and Follistatins: Further Thoughts on a Growing Family of Regulators 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[7]  T. Woodruff,et al.  The uterine myometrium is a target for increased levels of activin A during pregnancy. , 1997, Endocrinology.

[8]  R. Sharpe,et al.  Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. , 1997, Endocrinology.

[9]  N. Groome,et al.  Development, validation and application of a two-site enzyme-linked immunosorbent assay for activin-AB. , 1997, The Journal of endocrinology.

[10]  R. Anderson,et al.  Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. , 1997, Human reproduction.

[11]  A. Mcneilly,et al.  Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. , 1996, The Journal of clinical endocrinology and metabolism.

[12]  D. Robertson,et al.  Measurement of activin in biological fluids by radioimmunoassay, utilizing dissociating agents to remove the interference of follistatin. , 1996, European journal of endocrinology.

[13]  A. Mcneilly,et al.  Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. , 1996, The Journal of clinical endocrinology and metabolism.

[14]  F. Dunshea,et al.  The testis is not the major source of circulating follistatin in the ram. , 1996, The Journal of endocrinology.

[15]  N. Groome,et al.  Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. , 1996, The Journal of endocrinology.

[16]  M. Stefanini,et al.  Activin stimulates Sertoli cell proliferation in a defined period of rat testis development. , 1995, Endocrinology.

[17]  Jianming Xu,et al.  Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism (*) , 1995, The Journal of Biological Chemistry.

[18]  S. Muttukrishna,et al.  Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin. , 1994, The Journal of endocrinology.

[19]  K. Hildén,et al.  The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. , 1994, The Journal of clinical endocrinology and metabolism.

[20]  J. Mather,et al.  Inhibins, activins, their binding proteins and receptors: Interactions underlying paracrine activity in the testis , 1994, Molecular and Cellular Endocrinology.

[21]  P. Roberts,et al.  Follistatin modulates activin activity in a cell- and tissue-specific manner. , 1993, Endocrinology.

[22]  J. Findlay,et al.  Follistatins: More than follicle-stimulating hormone suppressing proteins , 1993, Molecular and Cellular Endocrinology.

[23]  N. Ling,et al.  Expression of inhibin beta A and beta B, follistatin and activin-A receptor messenger ribonucleic acids in the rat seminiferous epithelium. , 1992, Endocrinology.

[24]  N. Ling,et al.  Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. , 1991, Endocrinology.

[25]  N. Ling,et al.  FOLLISTATIN BINDS TO BOTH ACTIVIN AND INHIBIN THROUGH THE COMMON BETA-SUBUNIT , 1991 .

[26]  K. Titani,et al.  Activin-binding protein is present in pituitary. , 1991, Endocrinology.

[27]  G. Rice,et al.  Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis. , 1990, Endocrinology.

[28]  J. Findlay,et al.  Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. , 1990, Biochemical and biophysical research communications.

[29]  K. Titani,et al.  Activin-binding protein from rat ovary is follistatin. , 1990, Science.

[30]  N. Ling,et al.  Follistatin gene expression in the ovary and extragonadal tissues. , 1989, Molecular endocrinology.

[31]  G. Risbridger,et al.  Inhibin and activin regulate [3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro , 1989, Molecular and Cellular Endocrinology.

[32]  N. Ling,et al.  Primary structure of the human follistatin precursor and its genomic organization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Burger,et al.  The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. , 1987, Biochemical and biophysical research communications.

[34]  N. Ling,et al.  Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Tomokuni,et al.  The tissue distribution of diazinon and the inhibition of blood cholinesterase activities in rats and mice receiving a single intraperitoneal dose of diazinon. , 1985, Toxicology.

[36]  M. Matzuk,et al.  Overexpression of mouse follistatin causes reproductive defects in transgenic mice. , 1998, Molecular endocrinology.

[37]  H. Vanderstichele,et al.  Activin is produced by rat Sertoli cells in vitro and can act as an autocrine regulator of Sertoli cell function. , 1993, Endocrinology.

[38]  T. Woodruff,et al.  Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. , 1993, Endocrinology.